New research shows that reducing dietary protein may significantly lower liver cancer risk or slow its progression in people ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science ...

Experts have highlighted the potential of irpagratinib to become the first truly precision-targeted therapy for liver cancer. With FDA fast track designation now in place, Abbisko Therapeutics plans ...

Researchers identified FABP4 as a driver of MASLD-related liver cancer. They developed a monoclonal antibody that neutralizes ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

Hong Kong Polytechnic University researchers developed a novel antibody targeting fat cell proteins, opening potential ...

Nearly four in ten Indian adults may have metabolic fatty liver disease, with many already showing liver fibrosis, a new ...

This new review article highlights the critical role of ribosome biogenesis in liver health and disease progression. As the center of protein synthesis, ribosomes influence liver regeneration, ...

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, ...

Researchers assess the cost‐effectiveness of nivolumab plus ipilimumab vs lenvatinib or sorafenib for hepatocellular carcinoma from a US healthcare payer perspective.